Arya V - Search Results

1

Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.

Balkrishna A, Mittal R, Arya V. Balkrishna A, et al. Among authors: arya v. Curr Pharm Biotechnol. 2021;22(10):1350-1359. doi: 10.2174/1389201021999201110204116. Curr Pharm Biotechnol. 2021. PMID: 33176643

2

Unveiling Role of MicroRNAs as Treatment Strategy and Prognostic Markers in Triple Negative Breast Cancer.

Balkrishna A, Mittal R, Arya V. Balkrishna A, et al. Among authors: arya v. Curr Pharm Biotechnol. 2020;21(15):1569-1575. doi: 10.2174/1389201021666200627201535. Curr Pharm Biotechnol. 2020. PMID: 32593278 Review.

3

Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer.

Balkrishna A, Mittal R, Arya V. Balkrishna A, et al. Among authors: arya v. Curr Cancer Drug Targets. 2021;21(2):153-162. doi: 10.2174/1568009620999201103201626. Curr Cancer Drug Targets. 2021. PMID: 33155912 Review.

4

Computational insights of phytochemical-driven disruption of RNA-dependent RNA polymerase-mediated replication of coronavirus: a strategic treatment plan against coronavirus disease 2019.

Balkrishna A, Mittal R, Sharma G, Arya V. Balkrishna A, et al. Among authors: arya v. New Microbes New Infect. 2021 May;41:100878. doi: 10.1016/j.nmni.2021.100878. Epub 2021 Mar 31. New Microbes New Infect. 2021. PMID: 33815808 Free PMC article.

5

Mechanistic Insight into Antimicrobial and Antioxidant Potential of Jasminum Species: A Herbal Approach for Disease Management.

Balkrishna A, Rohela A, Kumar A, Kumar A, Arya V, Thakur P, Oleksak P, Krejcar O, Verma R, Kumar D, Kuca K. Balkrishna A, et al. Among authors: arya v. Plants (Basel). 2021 May 28;10(6):1089. doi: 10.3390/plants10061089. Plants (Basel). 2021. PMID: 34071621 Free PMC article. Review.

6

Anti-Cancer and Anti-Inflammatory Potential of Furanocoumarins from Ammi majus L.

Balkrishna A, Arya V, Sharma IP. Balkrishna A, et al. Among authors: arya v. Anticancer Agents Med Chem. 2022;22(6):1030-1036. doi: 10.2174/1871520621666210824113128. Anticancer Agents Med Chem. 2022. PMID: 34431469

7

Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer.

Balkrishna A, Mittal R, Arya V. Balkrishna A, et al. Among authors: arya v. Curr Cancer Drug Targets. 2021;21(11):907-918. doi: 10.2174/1568009621666210908113010. Curr Cancer Drug Targets. 2021. PMID: 34503412 Review.

8

Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines.

Balkrishna A, Arya V, Rohela A, Kumar A, Verma R, Kumar D, Nepovimova E, Kuca K, Thakur N, Thakur N, Kumar P. Balkrishna A, et al. Among authors: arya v. Vaccines (Basel). 2021 Oct 4;9(10):1129. doi: 10.3390/vaccines9101129. Vaccines (Basel). 2021. PMID: 34696237 Free PMC article. Review.

9

Phytoantioxidant Functionalized Nanoparticles: A Green Approach to Combat Nanoparticle-Induced Oxidative Stress.

Balkrishna A, Kumar A, Arya V, Rohela A, Verma R, Nepovimova E, Krejcar O, Kumar D, Thakur N, Kuca K. Balkrishna A, et al. Among authors: arya v. Oxid Med Cell Longev. 2021 Oct 26;2021:3155962. doi: 10.1155/2021/3155962. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34737844 Free PMC article. Review.

10

A Comprehensive Insight into the Phytochemical, Pharmacological Potential, and Traditional Medicinal Uses of Albizia lebbeck (L.) Benth.

Balkrishna A, Sakshi, Chauhan M, Dabas A, Arya V. Balkrishna A, et al. Among authors: arya v. Evid Based Complement Alternat Med. 2022 Apr 21;2022:5359669. doi: 10.1155/2022/5359669. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35497931 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results